Cellular changes in blood indicate severe respiratory disease during influenza infections in mice

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Dengler, Leonie ^a,b   Kühn, Nora ^a,b   Shin, Dai Lun ^a,b   Hatesuer, Bastian ^a,b   Schughart, Klaus ^a,b,c   Wilk, Esther ^a,b  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; GLYCOPROTEIN P 15095; HEMOGLOBIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; C57BL 6 MOUSE; CD3+ T LYMPHOCYTE; CELL INFILTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; DBA 2 MOUSE; DISEASE MARKER; DISEASE SEVERITY; FEMALE; GRANULOCYTE LYMPHOCYTE RATIO; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HISTOPATHOLOGY; HOST PATHOGEN INTERACTION; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL MONITORING; INFLUENZA A (H1N1); INNATE IMMUNITY; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; OXYGEN SATURATION; PREDICTIVE VALUE; THROMBOCYTE COUNT; VIRUS LOAD; VIRUS VIRULENCE; WEIGHT REDUCTION; ANIMAL; BLOOD; BLOOD CELL; BLOOD CELL COUNT; BREATHING DISORDER; C57BL MOUSE; CELL CULTURE; COMPLICATION; DBA MOUSE; DISEASE MODEL; DOG; GRANULOCYTE; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); LYMPHOCYTE; MORTALITY; ORTHOMYXOVIRUS INFECTION; PATHOGENICITY; PATHOLOGY; SEVERITY OF ILLNESS INDEX; VIROLOGY;

ANIMALS; BLOOD CELL COUNT; BLOOD CELLS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOGS; FEMALE; GRANULOCYTES; HOST-PATHOGEN INTERACTIONS; INFLUENZA A VIRUS, H1N1 SUBTYPE; LYMPHOCYTES; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; ORTHOMYXOVIRIDAE INFECTIONS; RESPIRATION DISORDERS; SEVERITY OF ILLNESS INDEX;

EID: 84904823139     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103149     Document Type: Article

References (42)

1. Fauci AS (2006) Seasonal and pandemic influenza preparedness: science and countermeasures. J Infect Dis 194 Suppl 2: S73-76.
2. Kilbourne ED (2006) Influenza pandemics of the 20th century. Emerg Infect Dis 12: 9-14.
3. Russell CJ, Webster RG (2005) The genesis of a pandemic influenza virus. Cell 123: 368-371. (Pubitemid 41546667)
4. Johnson NP, Mueller J (2002) Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic. Bull Hist Med 76: 105-115.
5. Neumann G, Noda T, Kawaoka Y (2009) Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459: 931-939.
6. Wang TT, Palese P (2009) Unraveling the mystery of swine influenza virus. Cell 137: 983-985.
7. Krug RM (2006) Virology. Clues to the virulence of H5N1 viruses in humans. Science 311: 1562-1563.
8. Gambotto A, Barratt-Boyes SM, de Jong MD, Neumann G, Kawaoka Y (2008) Human infection with highly pathogenic H5N1 influenza virus. Lancet 371: 1464-1475. (Pubitemid 351618340)
9. Kageyama T, Fujisaki S, Takashita E, Xu H, Yamada S, et al. (2013) Genetic analysis of novel avian A(H7N9) influenza viruses isolated from patients in China, February to April 2013. Euro Surveill 18: 20453.
10. Mancuso P (2013) Obesity and respiratory infections: does excess adiposity weigh down host defense? Pulm Pharmacol Ther 26: 412-419.
11. Karlsson EA, Marcelin G, Webby RJ, Schultz-Cherry S (2012) Review on the impact of pregnancy and obesity on influenza virus infection. Influenza Other Respir Viruses 6: 449-460.
12. Paquette SG, Banner D, Zhao Z, Fang Y, Huang SS, et al. (2012) Interleukin-6 Is a Potential Biomarker for Severe Pandemic H1N1 Influenza A Infection. PLoS ONE 7: e38214.
13. Woods CW, McClain TA, Chen M, Zaas KA, Nicholson PB, et al. (2013) A host transcriptional signature for presymptomatic detection of infection in humans exposed to influenza H1N1 or H3N2. PLoS ONE 8: e52198.
14. Boon AC, deBeauchamp J, Hollmann A, Luke J, Kotb M, et al. (2009) Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in mice. J Virol 83: 10417-10426.
15. Otte A, Sauter M, Alleva L, Baumgarte S, Klingel K, et al. (2011) Differential host determinants contribute to the pathogenesis of 2009 pandemic H1N1 and human H5N1 influenza A viruses in experimental mouse models. Am J Pathol 179: 230-239.
16. Pommerenke C, Wilk E, Srivastava B, Schulze A, Novoselova N, et al. (2012) Global transcriptome analysis in influenza-infected mouse lungs reveals the kinetics of innate and adaptive host immune responses. PLoS ONE 7: e41169.
17. Srivastava B, Blazejewska P, Hessmann M, Bruder D, Geffers R, et al. (2009) Host genetic background strongly influences the response to influenza a virus infections. PLoS ONE 4: e4857.
18. Trammell RA, Toth LA (2008) Genetic susceptibility and resistance to influenza infection and disease in humans and mice. Expert Rev Mol Diagn 8: 515-529. (Pubitemid 351962094)
19. Wilk E, Schughart K (2012) The mouse as model system to study host-pathogen interactions in influenza A infections. Curr Protoc Mouse Biol 2: 177-205.
20. Liedmann S, Hrincius ER, Anhlan D, McCullers JA, Ludwig S, et al. (2014) New virulence determinants contribute to the enhanced immune response and reduced virulence of an influenza A virus A/PR8/34 variant. J Infect Dis 209: 532-541.
21. Blazejewska P, Koscinski L, Viegas N, Anhlan D, Ludwig S, et al. (2011) Pathogenicity of different PR8 influenza A virus variants in mice is determined by both viral and host factors. Virology 412: 36-45.
22. Verhoeven D, Teijaro JR, Farber DL (2009) Pulse-oximetry accurately predicts lung pathology and the immune response during influenza infection. Virology 390: 151-156.
23. Koerner I, Kochs G, Kalinke U, Weiss S, Staeheli P (2007) Protective role of beta interferon in host defense against influenza A virus. J Virol 81: 2025-2030. (Pubitemid 46214473)
24. Herold S, von Wulffen W, Steinmueller M, Pleschka S, Kuziel WA, et al. (2006) Alveolar epithelial cells direct monocyte transepithelial migration upon influenza virus infection: impact of chemokines and adhesion molecules. J Immunol 177: 1817-1824. (Pubitemid 44092519)
25. Taut K, Winter C, Briles DE, Paton JC, Christman JW, et al. (2008) Macrophage Turnover Kinetics in the Lungs of Mice Infected with Streptococcus pneumoniae. Am J Respir Cell Mol Biol 38: 105-113.
26. Long JP, Kotur MS, Stark GV, Warren RL, Kasoji M, et al. (2013) Accumulation of CD11b(+)Gr-1 (+) cells in the lung, blood and bone marrow of mice infected with highly pathogenic H5N1 and H1N1 influenza viruses. Arch Virol 158: 1305-1322.
27. Baskin CR, Bielefeldt-Ohmann H, Tumpey TM, Sabourin PJ, Long JP, et al. (2009) Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc Natl Acad Sci U S A 106: 3455-3460.
28. Brandes M, Klauschen F, Kuchen S, Germain RN (2013) A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection. Cell 154: 197-212.
29. Tate MD, Ioannidis LJ, Croker B, Brown LE, Brooks AG, et al. (2011) The Role of Neutrophils during Mild and Severe Influenza Virus Infections of Mice. PLoS ONE 6: e17618.
30. Tate MD, Brooks AG, Reading PC (2008) The role of neutrophils in the upper and lower respiratory tract during influenza virus infection of mice. Respir Res 9: 57.
31. Gabrilovich DI, Nagaraj S (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9: 162-174.
32. Huang B, Pan PY, Li Q, Sato AI, Levy DE, et al. (2006) Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res 66: 1123-1131. (Pubitemid 43165981)
33. De Santo C, Salio M, Masri SH, Lee LY, Dong T, et al. (2008) Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans. J Clin Invest 118: 4036-4048.
34. Nagaraj S, Youn JI, Gabrilovich DI (2013) Reciprocal Relationship between Myeloid-Derived Suppressor Cells and T Cells. J Immunol 191: 17-23.
35. Belser JA, Wadford DA, Pappas C, Gustin KM, Maines TR, et al. (2010) Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice. J Virol 84: 4194-4203.
36. Belser JA, Szretter KJ, Katz JM, Tumpey TM (2009) Use of animal models to understand the pandemic potential of highly pathogenic avian influenza viruses. Adv Virus Res 73: 55-97.
37. Stark GV, Long JP, Ortiz DI, Gainey M, Carper BA, et al. (2013) Clinical profiles associated with influenza disease in the ferret model. PLoS ONE 8: e58337.
38. Fischbach F, Dunning MB III (2009) A manual of laboratory and diagnostic tests. Philadelphia: Wolters Kluwer Health; Lippincott Williams & Wilkins.
39. Chien YS, Su CP, Tsai HT, Huang AS, Lien CE, et al. (2010) Predictors and outcomes of respiratory failure among hospitalized pneumonia patients with 2009 H1N1 influenza in Taiwan. J Infect 60: 168-174.
40. Haidopoulou K, Goutaki M, Lemonaki M, Kavga M, Papa A (2011) Reactive thrombocytosis in children with viral respiratory tract infections. Minerva Pediatr 63: 257-262.
41. Indavarapu A, Akinapelli A (2011) Neutrophils to lymphocyte ratio as a screening tool for swine influenza. Indian J Med Res 134: 389-391.
42. Merekoulias G, Alexopoulos EC, Belezos T, Panagiotopoulou E, Jelastopulu DM (2010) Lymphocyte to monocyte ratio as a screening tool for influenza. PLoS Curr 2: RRN1154.